Previous nomination committees

Nomination Committee for the AGM 2023

The nomination committee for the AGM 2023 consisted of the following persons:

Clas Sonesson, Chief Scientific Officer (CSO) at IRLAB and one of IRLAB’s founders. Appointed by a group of shareholders that consists of the company’s founders representing slightly less than 14 per cent of shares and votes;
Hans-Peter Ostler, background from bank and investment advisory, appointed by a group of shareholders representing slightly more than 13 per cent of shares and votes;
Anders Vedin, background from executive positions in global pharmaceutical companies, appointed by a group of shareholders representing slightly more than 13 per cent of shares and votes; and
Carola Lemne, Chair of the Board of IRLAB Therapeutics AB.

The nomination committee for the AGM 2022 consisted of the following persons:

Daniel Johnsson, chairman of the nomination committee, entrepreneur, business developer and investor, appointed by a group of shareholders representing about 21 percent of shares and votes;
Bo Rydlinger, background from banking and investments, appointed by a group of shareholders representing about 15 percent of shares and votes;
Clas Sonesson, Chief Scientific Officer (CSO) at IRLAB and one of IRLAB’s founders. Appointed by a group of shareholders that consists of the company’s founders representing about 10 percent of shares and votes; and
Gunnar Olsson, chairman of the board of IRLAB Therapeutics AB.

The nomination committee for the AGM 2021 consisted of the following persons:

Daniel Johnsson, chairman of the nomination committee, entrepreneur, business developer and investor, appointed by a group of shareholders representing about 23 percent of shares and votes;
Bo Rydlinger, background from banking and investments, appointed by a group of shareholders representing about 19 percent of shares and votes;
Clas Sonesson, Chief Scientific Officer (CSO) at IRLAB and one of IRLAB’s founders. Appointed by a group of shareholders that consists of the company’s founders representing about 11 percent of shares and votes; and
Gunnar Olsson, chairman of the board of IRLAB Therapeutics AB.

The nomination committee for the AGM 2020 consisted of the following persons:

Bo Rydlinger, chairman of the nomination committee, background from banking and investments, appointed by a group of shareholders representing about 21 percent of shares and votes;
Daniel Johnsson, entrepreneur, business developer and investor, appointed by a group of shareholders representing about 24 percent of shares and votes;
Clas Sonesson, Chief Scientific Officer (CSO) at IRLAB and one of IRLAB’s founders. Appointed by a group of shareholders that consists of the company’s founders representing about 13 percent of shares and votes; and
Anders Vedin, chairman of the board of IRLAB Therapeutics AB.

The nomination committee for the AGM 2019 consisted of the following persons:

Bo Rydlinger, background from banking and investments, appointed by a group of shareholders representing almost 24 per cent of shares and votes,
Daniel Johnsson, entrepreneur, business developer and investor, appointed by a group of shareholders representing more than 21 per cent of shares and votes,
Olle Stenberg, experience from business development and management, appointed by a group of shareholders that consists of the company’s founders representing more than 13 percent of shares and votes, and
Anders Vedin, chairman of the board of IRLAB Therapeutics AB.

The nomination committee for the AGM 2018 consisted of the following persons:

Bo Rydlinger, many years’ experience from banking and investments, appointed by a group of shareholders representing more than 17 per cent of shares and votes,
Erik Klinton, lawyer specialised in tax law, appointed by a group of shareholders that consists of the company’s founders representing more than 13 percent of shares and votes,
John D. Wakely, based in the UK with long experience from international financial markets, appointed by Sievert Larsson Scholarship Foundation which own 10 per cent of shares and votes, and
Anders Vedin, chairman of the board of IRLAB Therapeutics AB.

The nomination committee for the AGM 2017 consisted of the following persons: